Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of ...

Biohaven is giving investors whiplash. Forty-eight hours after saying its filing was on track, the biopharma revealed the FDA ...

In its yearly survey of international clinicians and patients, Philips illustrated significant gaps in people’s trust when it ...

The Garden State is looking to grow into the next big biotech hub. | The Garden State is looking to grow into the next big ...

WASHINGTON — FDA Commissioner Martin Makary offered more details into the agency’s recently announced plans to place ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...